Prescription medicine
Beclomethasone Brand names: Qvar, Qnasl; first approved as Vanceril
Beclomethasone (Qvar) is a prescription medicine with an FDA approval on record since 1976. A generic is approved and listed by 2 labelers, but in the October 7, 2026 NADAC survey pharmacies bought only the brand, at $30.23 per gram (Qnasl 80 mcg nasal spray).
- Generic approved
Check it at the source: the beclomethasone FDA label on DailyMed (effective June 25, 2024, A-S Medication Solutions); the NDA 17573 record on Drugs@FDA; every beclomethasone label on DailyMed.
Highlights of the record
FDA label of June 25, 2024; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026; NADAC October 7, 2026
Used for
From the label: indications and usageQVAR REDIHALER is indicated in the maintenance treatment of asthma as prophylactic therapy in adults and pediatric patients 4 years of age and older.
Forms and strengths
Aerosol (metered).
On the market
- Earliest approval on file
- May 12, 1976 Vanceril, Schering; Drugs@FDA’s file, where older or withdrawn approvals can be missing
- Generic approvals
- 2 first December 16, 2025; 2 with a marketed status in Drugs@FDA
- Labelers listed (NDC)
- 4 of which 2 under generic applications, 2 under brand applications, repackagers included
- Last listed patent
- August 19, 2041 Qvar Redihaler aerosol; not a generic launch date
Supply and safety
- Pharmacy cost (NADAC)
- $30.23 per gram Qnasl 80 mcg nasal spray
- Shortage (FDA)
- No current entry
- Recalls by its makers (FDA)
- No recall recorded
- FAERS reports
- 5,600 through July 30, 2026
What is beclomethasone used for?
From the label: indications and usageQVAR REDIHALER is indicated in the maintenance treatment of asthma as prophylactic therapy in adults and pediatric patients 4 years of age and older. Limitations of Use: QVAR REDIHALER is not indicated for the relief of acute bronchospasm. QVAR REDIHALER is a corticosteroid indicated for maintenance treatment of asthma as prophylactic therapy in adults and pediatric patients 4 years of age and older. ( 1 ) Limitations of Use: Not indicated for the relief of acute bronchospasm.
Conditions named in the indications of beclomethasone's FDA labels, with every medicine labeled for each:
From other beclomethasone labelsAllergies: QNASL Nasal Aerosol is a corticosteroid indicated for the treatment of nasal symptoms associated with seasonal and perennial allergic rhinitis in patients 4 years of age and older.
FDA pharmacologic class: Corticosteroid.
Source: FDA drug label (QVAR REDIHALER), NDA207921 (Norton Waterford), as published by A-S Medication Solutions, effective June 25, 2024 (SPL set ccd3aaec-4892-40d0-ad60-3e570178fbe1), via openFDA; the full label on DailyMed
What does the patient leaflet for beclomethasone say first?
The FDA-approved Medication Guide or Patient Information that comes with the medicine, in its own words.
From the patient leaflet: What should I avoid while using QVAR REDIHALER?If you have not had, or have not been vaccinated against, chickenpox or measles, you should stay away from people who are infected.
From the patient leaflet: How should I store QVAR REDIHALER?Store QVAR REDIHALER at room temperature between 68ºF to 77ºF (20ºC to 25ºC). Avoid exposure to extreme heat or cold. Keep the white cap on the inhaler closed during storage. Keep your QVAR REDIHALER inhaler dry and clean at all times. Clean the mouthpiece of your QVAR REDIHALER weekly with a clean, dry tissue or cloth. Your QVAR REDIHALER canister should only be used with the QVAR REDIHALER actuator. Do not use any other medicines in your QVAR REDIHALER actuator. The contents of your QVAR REDIHALER canister are under pressure. Do not puncture the QVAR REDIHALER canister. Do not take QVAR REDIHALER apart. If you drop your QVAR REDIHALER, inspect it for damage before use. If the QVAR REDIHALER is damaged, do not use the damaged QVAR REDIHALER. Call your healthcare provider or pharmacist to replace the QVAR REDIHALER. Do not store your QVAR REDIHALER canister near heat or a flame. […]
Source: FDA drug label (QVAR REDIHALER), NDA207921 (Norton Waterford), as published by A-S Medication Solutions, effective June 25, 2024 (SPL set ccd3aaec-4892-40d0-ad60-3e570178fbe1), via openFDA; the full label on DailyMed
Is there a generic for beclomethasone (Qvar)?
The FDA approved the first generic beclomethasone on December 16, 2025. 2 generic applications are approved; 2 of them carry a current (not discontinued) marketing status in Drugs@FDA; that status is not evidence that the generic is on sale.
FDA's NDC Directory lists beclomethasone from 2 labelers under a generic (ANDA) application and from 2 brand labelers. A listing means the company has registered the product for sale; it does not show that every pharmacy stocks it. In the latest NADAC survey pharmacies bought only the brand, so a generic may not be on sale yet.
The Orange Book lists 17 patents for Qvar Redihaler aerosol, the last expiring on August 19, 2041. A patent or exclusivity date is not the date a generic goes on sale: court cases and settlements move it either way.
- 1976 earliest approval on file
- 2025 first generic approved
- 2041 last listed patent
Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)
What do pharmacies pay for beclomethasone (Qvar)?
In CMS's NADAC survey of October 7, 2026, pharmacies paid $30.23 per gram (Qnasl 80 mcg nasal spray), up 5% from $28.89 on October 8, 2025. The chart's scale runs from the lowest to the highest price shown, not from zero. NADAC is what retail pharmacies paid their wholesalers, per unit, in CMS's monthly survey; what a patient pays depends on insurance and the pharmacy.
- Qvar redihaler 40 mcg (brand)
| Strength and form | Brand or generic | Pharmacy cost | 30 tablets, or one pen or vial | 12-month change |
|---|---|---|---|---|
| Qnasl 80 mcg nasal spray | Brand | $30.23 per gram | n/a | +5% |
| Qnasl children's 40 mcg spray | Brand | $47.08 per gram | n/a | +5% |
| Qvar redihaler 40 mcg | Brand | $20.57 per gram | n/a | +4% |
| Qvar redihaler 80 mcg | Brand | $27.57 per gram | n/a | +4% |
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price
What does the beclomethasone label say about other medicines?
The beclomethasone label names 1 other medicine in its interaction, contraindication or warning sections. The labels of 10 other medicines name beclomethasone. The sentences are the labels' own; a label lists what its studies and reports found, not every interaction.
| Medicine named | Section | What the label says |
|---|---|---|
| Prednisone | warnings and precautions | Patients who have been previously maintained on 20 mg or more per day of prednisone (or its equivalent) may be most susceptible, particularly when their systemic corticosteroids have been almost completely withdrawn. |
Other labels that name beclomethasone
Source: FDA drug label (QVAR REDIHALER), NDA207921 (Norton Waterford), as published by A-S Medication Solutions, effective June 25, 2024 (SPL set ccd3aaec-4892-40d0-ad60-3e570178fbe1), via openFDA; the full label on DailyMed
What do FAERS reports show for beclomethasone?
The FDA Adverse Event Reporting System holds 5,600 reports that list beclomethasone among the medicines taken, through July 30, 2026, each a report of something that happened, not proof the medicine caused it; 536 are coded as a death and 2,027 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.
Reports received each year
The most reported reactions
Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026
What else is labeled for the same conditions as beclomethasone?
13 other medicines are given the same way (respiratory (inhalation)) and in the same FDA class as beclomethasone or labeled mainly for the same use (asthma), the same class first. Asthma lists all 37 medicines labeled for it, by any route. The first 8 are below. They are listed as records, not as substitutes: whether one can replace another is a prescriber's decision.
| Medicine | Shared indication | Generic labelers (respiratory (inhalation)) | Pharmacy cost | Shortage |
|---|---|---|---|---|
| Fluticasone and salmeterol | Asthma | 8 labelers | $1.07 per unit 100-50 | A presentation being discontinued |
| Budesonide | Asthma | 13 labelers | $0.676 per mL 0.5 mg/2 mL suspension | No current entry |
| Fluticasone | Asthma, Allergies | 1 labeler | $11.82 per gram 44 mcg inhaler | No current entry |
| Budesonide and formoterol | Asthma | 2 labelers | $17.26 per gram 160-4.5 | No current entry |
| Fluticasone and vilanterol | Asthma | none listed | $3.90 per unit 100-25 | No current entry |
| Mometasone | Asthma | none listed | $6.84 per gram 50 mcg inhaler | No current entry |
| Formoterol and mometasone | Asthma | none listed | $25.22 per gram 100 mcg-5 mcg inhaler | No current entry |
| Budesonide and formoterol and glycopyrrolate | Asthma | none listed | $61.41 per gram 160-9-4.8 mcg | No current entry |
Every medicine labeled for the same conditions as beclomethasone
Source: FDA drug labels (indications), NDC Directory, NADAC of October 7, 2026, FDA shortages (October 8, 2026)
How does beclomethasone compare with medicines for the same use?
4 side-by-side pages set beclomethasone beside a medicine whose label shares a use: approvals, generics, pharmacy cost, warnings and supply.
What next?
- Alternatives to beclomethasone
- 13 medicines for the same use
- Other corticosteroids
- the pharmacologic class, with prices and generics
- Beclomethasone side effects
- the label's list beside FAERS reports
- Check an interaction
- what two or more labels say about each other